(Q34036214)

English

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

multivariate statistics

1 reference

based on heuristic

inferred from title

Candida albicans

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

invasive candidiasis

1 reference

based on heuristic

inferred from title

9

object named as

Thomas J Walsh

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Peter G. Pappas

4

object named as

Peter G Pappas

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

object named as

Andrew F Shorr

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Annette C. Reboli

1

object named as

Annette C Reboli

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Coleman Rotstein

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Daniel H Kett

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Haran T Schlamm

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Arlene L Reisman

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pinaki Biswas

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

full work available at URL

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203347

1 reference

21 March 2022

BMC Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

261

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

30 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Anidulafungin versus fluconazole for invasive candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Anidulafungin: a new echinocandin for candidal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Epidemiology of invasive candidiasis: a persistent public health problem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Cardiac failure in C5-deficient A/J mice after Candida albicans infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Changing patterns and trends in systemic fungal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Caspofungin: an echinocandin antifungal agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203347

5 July 2018

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

Candida albicans RFX2 encodes a DNA binding protein involved in DNA damage responses, morphogenesis, and virulence

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

Effect of inducible nitric oxide synthase on apoptosis in Candida-induced acute lung injury

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

High dissemination and hepatotoxicity in rats infected with Candida albicans after stress exposure: potential sensitization to liver damage

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-261

21 January 2018

Guidelines for treatment of candidiasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21961941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21961941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mice with disseminated candidiasis die of progressive sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21961941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21961941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-11-261

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

release_xpa4b5asmzcnviuvqw5j7nez3q

1 reference

https://api.fatcat.wiki/v0/release/xpa4b5asmzcnviuvqw5j7nez3q

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34036214&oldid=2196152995"